Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
about
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth.Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma.Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.
P2860
Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
@ast
Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
@en
type
label
Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
@ast
Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
@en
prefLabel
Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
@ast
Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
@en
P2093
P1476
Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
@en
P2093
P356
10.1016/S0959-8049(96)00317-6
P478
32A Suppl 4
P577
1996-01-01T00:00:00Z